Medicenna Therapeutics
Temi Adeyemo has a diverse work experience in the field of clinical research. Currently, Temi works at Medicenna Therapeutics Corp. as a Lead Clinical Research Associate since January 2023, after previously serving as a Senior Clinical Research Associate from March 2022. Before joining Medicenna Therapeutics Corp., Temi gained valuable experience at ICON plc starting in February 2021 as a Senior Clinical Research Associate, overseeing multiple research sites, ensuring accurate patient records, and communicating issues to the CTM. Prior to that, Temi served as a Clinical Research Associate II from June 2018, conducting various visits at research sites in compliance with approved protocols. Temi's career in clinical research began at Johnson & Johnson in January 2016 as a Clinical Research Associate I, assisting the clinical team in screening potential study participants. Temi's earlier work experience includes serving as a Clinical Research Coordinator at Princess Margaret Hospital from January 2015 to January 2016, where they performed various study start-up duties and implemented effective recruitment plans.
From 2004 to 2010, Temi Adeyemo attended Ladoke Akintola University of Technology, where they earned a Bachelor of Science degree in Biochemistry.
This person is not in any offices
Medicenna Therapeutics
1 followers
Medicenna Therapeutics is a clinical-stage immunotherapy company developing novel highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines (ECs). Their mission is to become the leader in the development and commercialization of targeted ECs and Superkines for the treatment of a broad range of cancers and immune-mediated diseases.